SEARCH

SEARCH BY CITATION

References

  • Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet23:185188.
  • Archer HL, Evans J, Edwards S, Colley J, Newbury-Ecob R, O’Callaghan F, Huyton M, O’Regan M, Tolmie J, Sampson J, Clarke A, Osborne J. (2006) CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet43:729734.
  • Archer H, Evans J, Leonard H, Colvin L, Ra-vine D, Christodoulou J, Williamson S, Charman T, Bailey ME, Sampson J, de Klerk N, Clarke A. (2007) Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X- chromosome inactivation. J Med Genet44:148152.
  • Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A, Pollazzon M, Buoni S, Spiga O, Ricciardi S, Meloni I, Longo I, Mari F, Broccoli V, Zappella M, Renieri A. (2008) FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet83:8993.
  • Armstrong DD. (2005) Neuropathology of Rett syndrome. J Child Neurol20:747753.
  • Bahi-Buisson N, Nectoux J, Rosas-Vargas H, Milh M, Boddaert N, Girard B, Cances C, Ville D, Afenjar A, Rio M, Héron D, N’guyen Morel MA, Arzimanoglou A, Philippe C, Jonveaux P, Chelly J, Bienvenu T. (2008a) Key clinical features to identify girls with CDKL5 mutations. Brain131:26472661.
  • Bahi-Buisson N, Kaminska A, Boddaert N, Rio M, Afenjar A, Gérard M, Giuliano F, Motte J, Héron D, Morel MA, Plouin P, Richelme C, des Portes V, Dulac O, Philippe C, Chiron C, Nabbout R, Bienvenu T. (2008b) The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia49:10271037.
  • Bahi-Buisson N, Girard B, Gautier A, Nectoux J, Fichou Y, Saillour Y, Poirier K, Chelly J, Bienvenu T. (2010) Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene. Am J Med Genet B Neuropsychiatr Genet153B:202207.
  • Bertani I, Rusconi L, Bolognese F, Forlani G, Conca B, De Monte L, Badaracco G, Landsberger N, Kilstrup-Nielsen C. (2006) Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J Biol Chem281:3204832056.
  • Blue ME, Naidu S, Johnston MV. (1999a) Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol156:345352.
  • Blue ME, Naidu S, Johnston MV. (1999b) Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol45:541545.
  • Bourguignon C, Li J, Papalopulu N. (1988) XBF-1, a winged helix transcription factor with dual activity, has a role in positioning neurogenesis in Xenopus competent ectoderm. Development125:48894900.
  • Brooks-Kayal A. (2011) Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia52(Suppl. 1):1320.
  • Brunetti-Pierri N, Paciorkowski AR, Ciccone R, Mina ED, Bonaglia MC, Borgatti R, Schaaf CP, Sutton VR, Xia Z, Jelluma N, Ruivenkamp C, Bertrand M, de Ravel TJ, Jayakar P, Belli S, Rocchetti K, Pantaleoni C, D’Arrigo S, Hughes J, Cheung SW, Zuffardi O, Stankiewicz P. (2011) Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment. Eur J Hum Genet19:102107.
  • Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML, Vance JM, Pericak-Vance MA. (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol28:205211.
  • Carouge D, Host L, Aunis D, Zwiller J, Anglard P. (2010) CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis38:414424.
  • Carter JC, Lanham DC, Pham D, Bibat G, Naidu S, Kaufmann WE. (2008) Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study. AJNR Am J Neuroradiol29:436441.
  • Carvalho CM, Zhang F, Liu P, Patel A, Sahoo T, Bacino CA, Shaw C, Peacock S, Pursley A, Tavyev YJ, Ramocki MB, Nawara M, Obersztyn E, Vianna-Morgante AM, Stankiewicz P, Zoghbi HY, Cheung SW, Lupski JR. (2009) Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum Mol Genet18:21882203.
  • Casanova MF, Buxhoeveden D, Switala A, Roy E. (2003) Rett syndrome as a minicolumnopathy. Clin Neuropathol22:163168.
  • Castrén M, Gaily E, Tengström C, Lähdetie J, Archer H, Ala-Mello S. (2011) Epilepsy caused by CDKL5 mutations. Eur J Paediatr Neurol15:6569.
  • Chahrour M, Zoghbi HY. (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron56:422437.
  • Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science320:12241229.
  • Chen RZ, Akbarian S, Tudor M, Jaenisch R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet27:327331.
  • Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science302:885889.
  • Chen Q, Zhu YC, Yu J, Miao S, Zheng J, Xu L, Zhou Y, Li D, Zhang C, Tao J, Xiong ZQ. (2010) CDKL5, a protein associated with Rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J Neurosci30:1277712786.
  • Clayton-Smith J, Walters S, Hobson E, Burkitt-Wright E, Smith R, Toutain A, Amiel J, Lyonnet S, Mansour S, Fitzpatrick D, Ciccone R, Ricca I, Zuffardi O, Donnai D. (2009) Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance. Eur J Hum Genet17:434443.
  • Cohen D, Lazar G, Couvert P, Desportes V, Lippe D, Mazet P, Héron D. (2002) MECP2 mutation in a boy with language disorder and schizophrenia. Am J Psychiatry159:148149.
  • Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY. (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet13:26792689.
  • Dani VS, Nelson SB. (2009) Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J Neurosci29:1126311270.
  • Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB. (2005) Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA102:1256012565.
  • Del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M, Berry SA, Pursley AA, Grebe TA, Freedenberg D, Martin RA, Hsich GE, Khera JR, Friedman NR, Zoghbi HY, Eng CM, Lupski JR, Beaudet AL, Cheung SW, Roa BB. (2006) Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med8:784792.
  • Dou CL, Li S, Lai E. (1999) Dual role of brain factor-1 in regulating growth and patterning of the cerebral hemispheres. Cereb Cortex9:543e50.
  • Eagleson KL, Schlueter McFadyen-Ketchum LJ, Ahrens ET, Mills PH, Does MD, Nickols J, Levitt P. (2007) Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon. Neuroscience148:385399.
  • Echenne B, Roubertie A, Lugtenberg D, Kleefstra T, Hamel BC, Van Bokhoven H, Lacombe D, Philippe C, Jonveaux P, de Brouwer AP. (2009) Neurologic aspects of MECP2 gene duplication in male patients. Pediatr Neurol41:187191.
  • Elia M, Falco M, Ferri R, Spalletta A, Bottitta M, Calabrese G, Carotenuto M, Musumeci SA, Lo Giudice M, Fichera M. (2008) CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology71:997999.
  • Glaze DG, Schultz RJ, Frost JD. (1998) Rett syndrome: charac- terization of seizures versus non-seizures. Electroencephalogr Clin Neurophysiol106:7983.
  • Glaze DG, Percy AK, Skinner S, Motil KJ, Neul JL, Barrish JO, Lane JB, Geerts SP, Annese F, Graham J, McNair L, Lee HS. (2010) Epilepsy and the natural history of Rett syndrome. Neurology74:909912.
  • Guerrini R, Bonanni P, Parmeggiani L, Santucci M, Parmeggiani A, Sartucci F. (1998) Cortical reflex myoclonus in Rett syndrome. Ann Neurol43:472479.
  • Hagberg BA, Skjeldal OH. (1994) Rett variants: a suggested model for inclusion criteria. Pediatr Neurol11:511.
  • Hagberg B, Aicardi J, Dias K, Ramos O. (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol14:471479.
  • Hanashima C, Li SC, Shen L, Lai E, Fishell G. (2004) Foxg1 suppresses early cortical cell fate. Science303:56e9.
  • Hirsch E, Velez A, Sellal F, Maton B, Grinspan A, Malafosse A, Marescaux C. (1993) Electroclinical signs of benign neonatal familial convulsions. Ann Neurol34:835841.
  • Huppke P, Held M, Laccone F, Hanefeld F. (2003) The spectrum of phenotypes in females with Rett syndrome. Brain Dev25:346351.
  • Jacob FD, Ramaswamy V, Andersen J, Bolduc FV. (2009) Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Genet17:15771581.
  • Jellinger KA. (2003) Rett syndrome – an update. J Neural Transm110:681701.
  • Jian L, Nagarajan L, de Klerk N, Ravine D, Christodoulou J, Leonard H. (2007) Seizures in Rett syndrome: an overview from a one-year calendar study. Eur J Paediatr Neurol11:310317.
  • Kalscheuer VM, Tao J, Donnelly A, Hollway G, Schwinger E, Kübart S, Menzel C, Hoeltzenbein M, Tommerup N, Eyre H, Harbord M, Haan E, Sutherland GR, Ropers HH, Gécz J. (2003) Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet72:14011411.
  • Kameshita I, Sekiguchi M, Hamasaki D, Sugiyama Y, Hatano N, Suetake I, Tajima S, Sueyoshi N. (2008) Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem Biophys Res Commun377:11621167.
  • Kankirawatana P, Leonard H, Ellaway C, Scurlock J, Mansour A, Makris CM, Dure LS IV, Friez M, Lane J, Kiraly-Borri C, Fabian V, Davis M, Jackson J, Christodoulou J, Kaufmann WE, Ravine D, Percy AK. (2006) Early progressive encephalopathy in boys and MECP2 mutations. Neurology67:164166.
  • Kleefstra T, Yntema HG, Oudakker AR, Romein T, Sistermans E, Nillessen W, van Bokhoven H, de Vries BB, Hamel BC. (2002) De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clin Genet61:359362.
  • Kortüm F, Das S, Flindt M, Morris-Rosendahl DJ, Stefanova I, Goldstein A, Horn D, Klopocki E, Kluger G, Martin P, Rauch A, Roumer A, Saitta S, Walsh LE, Wieczorek D, Uyanik G, Kutsche K, Dobyns WB. (2011) The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J Med Genet48:396406.
  • Leuzzi V, Di Sabato ML, Zollino M, Montanaro ML, Seri S. (2004) Early-onset encephalopathy and cortical myoclonus in a boy with MECP2 gene mutation. Neurology63:19681970.
  • Lin C, Franco B, Rosner MR. (2005) CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet14:37753786.
  • Lugtenberg D, Kleefstra T, Oudakker AR, Nillesen WM, Yntema HG, Tzschach A, Raynaud M, Rating D, Journel H, Chelly J, Goizet C, Lacombe D, Pedespan JM, Echenne B, Tariverdian G, O’Rourke D, King MD, Green A, van Kogelenberg M, Van Esch H, Gecz J, Hamel BC, van Bokhoven H, de Brouwer AP. (2009) Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur J Hum Genet17:444453.
  • Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S, Pescucci C, Ariani F, Hayek G, Balestri P, Bergo A, Badaracco G, Zappella M, Broccoli V, Renieri A, Kilstrup-Nielsen C, Landsberger N. (2005) CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet14:19351946.
  • Masliah-Plachon J, Auvin S, Nectoux J, Fichou Y, Chelly J, Bienvenu T. (2010) Somatic mosaicism for a CDKL5 mutation as an epileptic encephalopathy in males. Am J Med Genet A152A:21102111.
  • Matijevic T, Knezevic J, Slavica M, Pavelic J. (2009) Rett syndrome: from the gene to the disease. Eur Neurol61:310.
  • Mei D, Marini C, Novara F, Dalla Bernardina B, Granata T, Fontana E, Parrini E, Ferrari AR, Murgia A, Zuffardi O, Guerrini R. (2010) Xp22.3 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy. Epilepsia51:647654.
  • Melani F, Mei D, Pisano T, Savasta S, Franzoni E, Ferrari AR, Marini C, Guerrini R. (2011) CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life. Dev Med Child Neurol53:354360.
  • Mencarelli MA, Kleefstra T, Katzaki E, Papa FT, Cohen M, Pfundt R, Ariani F, Meloni I, Mari F, Renieri A. (2009) 14q12 Microdeletion syndrome and congenital variant of Rett syndrome. Eur J Med Genet52:148152.
  • Mencarelli MA, Spanhol-Rosseto A, Artuso R, Rondinella D, De Filippis R, Bahi-Buisson N, Nectoux J, Rubinsztajn R, Bienvenu T, Moncla A, Chabrol B, Villard L, Krumina Z, Armstrong J, Roche A, Pineda M, Gak E, Mari F, Ariani F, Renieri A. (2010) Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet47:4953.
  • Montini E, Andolfi G, Caruso A, Buchner G, Walpole SM, Mariani M, Consalez G, Trump D, Ballabio A, Franco B. (1998) Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. Genomics51:427433.
  • Muzio L, Mallamaci A. (2005) Foxg1 confines Cajal-Retzius neuronogenesis and hippocampal morphogenesis to the dorsomedial pallium. J Neurosci25:4435e41.
  • Nagai K, Miyake K, Kubota T. (2005) A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth. Brain Res Dev Brain Res157:103106.
  • Nemos C, Lambert L, Giuliano F, Doray B, Roubertie A, Goldenberg A, Delobel B, Layet V, N’guyen MA, Saunier A, Verneau F, Jonveaux P, Philippe C. (2009) Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature. Clin Genet76:357371.
  • Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, Zoghbi H, Percy A, Glaze DG. (2008) Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology70:13131321.
  • Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey ME, Schanen NC, Zappella M, Renieri A, Huppke P, Percy AK; RettSearch Consortium. (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol68:944950.
  • Paciorkowski AR, Thio LL, Rosenfeld JA, Gajecka M, Gurnett CA, Kulkarni S, Chung WK, Marsh ED, Gentile M, Reggin JD, Wheless JW, Balasubramanian S, Kumar R, Christian SL, Marini C, Guerrini R, Maltsev N, Shaffer LG, Dobyns WB. (2011) Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur J Hum Genet19:12381245.
  • Papa FT, Mencarelli MA, Caselli R, Katzaki E, Sampieri K, Meloni I, Ariani F, Longo I, Maggio A, Balestri P, Grosso S, Farnetani MA, Berardi R, Mari F, Renieri A. (2008) A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features. Am J Med Genet A146A:19941998.
  • Percy AK, Lane JB, Childers J, Skinner S, Annese F, Barrish J, Caeg E, Glaze DG, MacLeod P. (2007) Rett syndrome: North American database. J Child Neurol22:13381341.
  • Philippe C, Amsallem D, Francannet C, Lambert L, Saunier A, Verneau F, Jonveaux P. (2010) Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. J Med Genet47:5965.
  • Pintaudi M, Calevo MG, Vignoli A, Parodi E, Aiello F, Baglietto MG, Hayek Y, Buoni S, Renieri A, Russo S, Cogliati F, Giordano L, Canevini M, Veneselli E. (2010) Epilepsy in Rett syndrome: clinical and genetic features. Epilepsy Behav19:296300.
  • Ramocki MB, Tavyev YJ, Peters SU. (2010) The MECP2 duplication syndrome. Am J Med Genet A152A:10791088.
  • Rett A. (1966) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr116:723726.
  • Roth M, Bonev B, Lindsay J, Lea R, Panagiotaki N, Houart C, Papalopulu N. (2010) FoxG1 and TLE2 act cooperatively to regulate ventral telencephalon formation. Development137:15531562.
  • Rusconi L, Salvatoni L, Giudici L, Bertani I, Kilstrup-Nielsen C, Broccoli V, Landsberger N. (2008) CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem283:3010130111.
  • Sartori S, Di Rosa G, Polli R, Bettella E, Tricomi G, Tortorella G, Murgia A. (2009) A novel CDKL5 mutation in a 47, XXY boy with the early-onset seizure variant of Rett syndrome. Am J Med Genet A149A:232236.
  • Scala E, Ariani F, Mari F, Caselli R, Pescucci C, Longo I, Meloni I, Giachino D, Bruttini M, Hayek G, Zappella M, Renieri A. (2005) CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet42:103107.
  • Scala E, Longo I, Ottimo F, Speciale C, Samp-ieri K, Katzaki E, Artuso R, Mencarelli MA, D’Ambrogio T, Vonella G, Zappella M, Hayek G, Battaglia A, Mari F, Renieri A, Ariani F. (2007) MECP2 deletions and genotype-phenotype correlation in Rett syndrome. Am J Med Genet A143:27752784.
  • Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H. (2002a) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron35:243254.
  • Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. (2002b) Inight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet11:115124.
  • Shao L, Shaw CA, Lu XY, Sahoo T, Bacino CA, Lalani SR, Stankiewicz P, Yatsenko SA, Li Y, Neill S, Pursley AN, Chinault AC, Patel A, Beaudet AL, Lupski JR, Cheung SW. (2008) Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases. Am J Med Genet146A:22422251.
  • Shoichet SA, Kunde SA, Viertel P, Schell-Apacik C, von Voss H, Tommerup N, Ropers HH, Kalscheuer VM. (2005) Haploinsufficiency of novel FOXG1B variants in a patient with severe mental retardation, brain malformations and microcephaly. Hum Genet117:536e44.
  • Siegenthaler JA, Tremper-Wells BA, Miller MW. (2008) Foxg1 haploinsufficiency reduces the population of cortical intermediate progenitor cells: effect of increased p21 expression. Cereb Cortex18:18651875.
  • Smrt RD, Eaves-Egenes J, Barkho BZ, Barkho BZ, Santistevan NJ, Zhao C, Aimone JB, Gage FH, Zhao X. (2007) Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis27:7789.
  • Steffenburg U, Hagberg G, Hagberg B. (2001) Epilepsy in a representative series of Rett syndrome. Acta Paediatr90:3439.
  • Striano P, Paravidino R, Sicca F, Chiurazzi P, Gimelli S, Coppola A, Robbiano A, Traverso M, Pintaudi M, Giovannini S, Operto F, Vigliano P, Granata T, Coppola G, Romeo A, Specchio N, Giordano L, Osborne LR, Gimelli G, Minetti C, Zara F. (2011) West syndrome associated with 14q12 duplications harboring FOXG1. Neurology76:16001602.
  • Tao W, Lai E. (1992) Telencephalon-restricted expression of BF-1, a new member of the HNF-3/fork head gene family, in the developing rat brain. Neuron8:957e66.
  • Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, Sperner J, Fryns JP, Schwinger E, Gécz J, Ropers HH, Kalscheuer VM. (2004) Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet75:11491154.
  • Van Esch H, Jansen A, Bauters M, Froyen G, Fryns JP. (2007) Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes. Am J Med Genet143:364369.
  • Vignoli A, Borgatti R, Peron A, Zucca C, Ballarati L, Bonaglia C, Bellini M, Giordano L, Romaniello R, Bedeschi MF, Epifanio R, Russo S, Caselli R, Giardino D, Darra F, La Briola F, Banderali G, Canevini MP. (2012) Electroclinical pattern in MECP2 duplication syndrome: eight new reported cases and review of literature. Epilepsia53:11461155.
  • Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U. (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet65:15201529.
  • Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, Archer H, Evans J, Clarke A, Pelka GJ, Tam PP, Watson C, Lahooti H, Ellaway CJ, Bennetts B, Leonard H, Gécz J. (2004) Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet75:10791093.
  • White R, Ho G, Schmidt S, Scheffer IE, Fischer A, Yendle SC, Bienvenu T, Nectoux J, Ellaway CJ, Darmanian A, Tong X, Cloosterman D, Bennetts B, Kalra V, Fullston T, Gecz J, Cox TC, Christodoulou J. (2010) Cyclin-dependent kinase-like 5 (CDKL5) mutation screening in Rett syndrome and related disorders. Twin Res Hum Genet13:168178.
  • Xuan S, Baptista CA, Balas G, Tao W, Soares VC, Lai E. (1995) Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron14:1141e52.
  • Yeung A, Bruno D, Scheffer IE, Carranza D, Burgess T, Slater HR, Amor DJ. (2009) 4.45 Mb microduplication in chromosome band 14q12 including FOXG1 in a girl with refractory epilepsy and intellectual impairment. Eur J Med Genet52:440442.